Gynuity Health Projects

Sharing an account of our 2025 activities gynuity.org/annual-repor.... Read about collaborative research responding to the gap in number & type of abortion products; supporting omission of preabortion screening tests; fostering strategies to improve PPH outcomes.

Newsletter: Vol 9, No. 2, December 2025 Email from Gynuity Health Projects   ABOUT OUR WORK NEWS & EVENTS RESOURCES IMAGE BANK Introduction December 10th, 2025 In this issue, read about progress in our study to validate a medication abortio

Our latest newsletter myemail.constantcontact.com/Newsletter--...
▶️ a study to validate a medication abortion regimen using ulipristal acetate
▶️evidence & data from research helping to influence policy & practice decisions
▶️the impact of funding cuts on a study assessing a telemedicine care model

Gynuity’s president is honored with a Special Award of Recognition by the Georgian Society of Contraception & Reproductive Health for contributions to safe abortion access in the Republic of Georgia.This is really a lovely gesture from our colleagues in Tbilisi! Read more gynuity.org/news/gynuity...

Five Things to Know About Missed Period Pills Missed period pills bring back your period when it’s late and safely end a potential early pregnancy—no pregnancy test required.

Five Things to Know About Missed Period Pills, from @carafem.org and @msmagazine.com

3. Many people prefer to skip the test
A 2020 study by @gynuity.bsky.social found nearly half of the 678 participants would choose same-day pills without a pregnancy test—and 70% of those who didn’t want to be pregnant said the same. Many said that skipping the test would reduce stress and stigma.🧵

Happy #PublicationDay, @rebeccakelliher.bsky.social! 🎆

JUST PILLS, the radical history of the abortion pills from invention to distribution to today, “is essential reading for anyone who cares about the attacks on our bodies and freedoms.” — @jessicavalenti.bsky.social

A flat lay photo shows a Mifeprex (mifepristone) box with a single round white pill and a green pill bottle with several white hexagonal tablets spilled out on a light circular background. Text above reads “Missed period pills,” and text below says, “A safe and evidence-backed way to bring back your period.” The design uses bold white and pink text on a dark green background.

If your period is late & you don’t want to be pregnant, do you really have to wait for a positive pregnancy test before you can act? With missed period pills from carafem, you can take action to bring back your period & peace of mind by safely ending a potential early pregnancy.

Congratulations to everyone involved in this comprehensive analysis addressing important questions on excessive bleeding after childbirth >>>

Welcome news. A new generic mifepristone product was approved for use by the US Food and Drug Administration in September 2025 for terminating an early pregnancy, up to 70 days from the first day of the last menstrual period
www.evitasolutionsllc.com

In reply to calls from prospective funders seeking to support abortion access/rights, we were identified as an impactful org working in this space www.bridgespan.org/insights/opp... If you'd like to explore your philanthropic journey with us, reach out to discuss how we can partner together

In the latest issue of our Newsletter gynuity.org/news/newslet..., read about ongoing research into ulipristal acetate for medication abortion, patient experiences with asynchronous medication abortion care, & a conference on advancing access to self-care interventions for reproductive health

The selection and use of essential medicines, 2025: WHO Model List of Essential Medicines, 24th list Essential medicines are those that satisfy the priority health care needs of a population. They are selected with due regard to disease prevalence and public health relevance, evidence of efficacy and...

The updated WHO List of Essential Medicines is available. For the first time, abortion medicines are presented in a new section &, in a positive move, the list no longer carries the caveat that singled out mifepristone & misoprostol as only to be used where legally permitted or culturally acceptable

This evaluation builds upon a study by @gynuity.bsky.social with @ppnorthcentral.bsky.social @pprockymountains.bsky.social, which suggests that providing medication abortion based only on a self-administered, programmed questionnaire is likely to be effective and safe gynuity.org/resources/ev...

A qualitative study examining patient experiences with asynchronous medication abortion care in the US found that care without real-time interaction with a physician is highly acceptable to patients, enabling them to avoid unnecessary care with providers www.sciencedirect.com/science/arti...

📢 New: Abortion care guideline, 2nd edition

A consolidated reference of all WHO recommendations & best practices on abortion—covering law & policy, clinical services & service delivery.

🔗 bit.ly/45N7ehK

#SRHR #HealthForAll

Through this letter organized by CRHLP and ANSIRH, hundreds of researchers remind the FDA that it’s actions must be based on the sound, rigorous, and transparent science that conclusively proves the safety and effectiveness of mifepristone generally and via telehealth.

Today we and our colleagues at @‪ansirh.bsky.social‬ submitted a letter to the FDA for over 260 researchers affirming the 25-year safety record of mifepristone and urging the FDA not to restrict abortion pill access based on junk science. Read the letter here: law.ucla.edu/sites/defaul...

Center on Reproductive Health, Law, and Policy Reproductive Health Researchers Comment Letter to FDA On August 27th, 2025, UCLA Center on Reproductive Health, Law, and Policy (CRHLP) and Advancing New Standards in Reproductive Health (ANSIRH) at UCSF submitted a letter on behalf of more than 260 rese...

Today we submitted a letter with @uclarepropolicy.bsky.social to the FDA signed by over 200 scientists.

The short version? Medication abortion is safe. Time to drop the junk science and move on. law.ucla.edu/reproductive...

Congratulations to all behind TEACH's updated abortion training curriculum. Essential new resource >>>

🎧In the FMUS podcast series, host @francoisegirard.bsky.social gets together with
@gynuity.bsky.social president Beverly Winikoff to discuss new groundbreaking research into ulipristal acetate for medication abortion. Tune into Ep. 13 www.fmus.org/fmus-podcast

The FDA’s ‘data guy’ should trust the data on the abortion pill FDA Commissioner Marty Makary’s pledge to reexamine the safety of medication abortion isn’t just pointless — it’s dangerous.

"Makary, who proudly calls himself a 'data guy' should have no trouble acknowledging that the science behind mifepristone is rock solid—and it hasn’t changed."

📣My new op-ed with @heyjane.com's Kiki Fredman that calls on @fda.gov to trust the data on the #abortion pill!

thehill.com/opinion/heal...

Este FAQ (preguntas frecuentes) también está disponible en español gynuity.org/assets/resou...

@carrienbaker.bsky.social's excellent tribute to the extraordinary Dr. Étienne-Émile Baulieu, the French scientist behind RU 486, also known as mifepristone >>>

Why the US aid cuts are a moment to prioritize reproductive health Why the US aid cuts are a moment to prioritize reproductive health

As the Trump administration cuts foreign aid, reproductive health leaders are urging donors to keep prioritizing women and girls.

The ‘Study’ Driving the FDA’s Abortion-Pill Agenda RFK Jr.’s affection for junk science has struck again.

I wrote for @theatlantic.com about the latest "data" RFK Jr. is using to advance bad policy. This time, he's coming for abortion. www.theatlantic.com/health/archi...

The Right to Abortion in Nepal: A Decades-Long Journey | Center for Reproductive Rights New documentary showcases the progress of abortion from criminalization to a fundamental, constitutional right. Documentary showcases the progress of abortion from criminalization to a fundamental, co...

Two decades ago in Nepal, a woman seeking an abortion would be denied care. Today, the right to abortion is guaranteed in Nepal’s Constitution. Check out this new documentary (23 mins) Collective Voyage: A tireless journey for ensuring the right to safe abortion in Nepal.

Data from a published study support the potential of ulipristal acetate as an alternative medicine for medication abortion. We have compiled a list of Frequently Asked Questions to provide quick and accessible answers to common queries about our early-stage research>>> gynuity.org/resources/fa...

We're pleased to share our annual report. This report provides an account of our activities in 2024 to strengthen safe and effective reproductive and maternal health care access worldwide. Read our digital report, available in English only gynuity.org/annual-repor...

‪Hello from Gynuity Health Projects' official @bsky.app account. Follow us here for our latest work on strengthening access to reproductive & maternal health care through clinical and programmatic research www.gynuity.org